The global Life Sciences Software market is valued at ~$11 billion in 2020 and is expected to grow at a CAGR of ~11% to reach $18 billion by 2025. The Life Sciences Software market growth is being fueled by increased R&D efforts around the globe, stringent regulatory compliance/reporting, increasing use of AI & ML during the drug discovery and clinical trial phases, and growing demand for novel software solutions especially designed for biologics/cell, and gene therapy.